Healthcare
Live Price
Offline$35.05
-0.14% today
1Y Change
+47.41%
Window
Jun 20, 2025 → May 29, 2026
Coverage: 237 bars · Jun 20, 2025 → May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sonida Senior Living, Inc. (SNDA) is a Healthcare stock with a market cap of $680.00M and listed on NYSE. The stock last traded around $35.05 and up 47.4% across the available one-year price window (Jun 20, 2025 → May 29, 2026). Baseline metrics include revenue growth of +25.2%, EPS growth of -681.5%, a dividend yield of 0.0%. What stands out right now is revenue +25.2%, EPS -681.5%, free cash flow +66.9% with operating margin -15.3% and ROIC -7.8%. Valuation is more restrained than many high-expectation growth names at price/sales 1.8. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SNDA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SNDA
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SNDA Max Drawdown
-16.39%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SNDA and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$234.7M
-1.6% YoY
FY Net Income
$125.6M
+330.9% YoY
Free Cash Flow
-$39.2M
-44.6% YoY
Revenue Growth
+25.2%
EPS Growth
-681.5%
Gross Margin
-8.0%
Net Margin
-18.6%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 381M | 304M | 255M | 238M | 235M |
| Gross Profit | -30M | 271M | 234M | 211M | 194M |
| Operating Income | -58M | -15M | -15M | -29M | -34M |
| EBITDA | 23M | 78M | 55M | 17M | 201M |
| Net Income | -71M | -2M | -21M | -54M | 126M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 11M | 17M | 4M | 17M | 79M |
| Total Assets | 845M | 842M | 621M | 661M | 729M |
| Total Liabilities | 789M | 712M | 688M | 719M | 734M |
| Shareholder Equity | 51M | 123M | -67M | -58M | -6M |
| Total Debt | 690M | 651M | 629M | 671M | 684M |
| Net Debt | 679M | 634M | 625M | 654M | 605M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
29M
-1017.0% YoY
Capital Expenditures
10M
+57.5% YoY
Free Cash Flow
39M
-44.6% YoY
Key ratios
Gross Margin
-8.0%
Operating Margin
-15.3%
Net Margin
-18.6%
ROE
-80.8%
Debt / Equity
13.46x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.